Journal of Psychosomatic Research
Volume 67, Issue 6 , Pages 547-557 , December 2009

The PANDAS subgroup of tic disorders and childhood-onset obsessive–compulsive disorder

  • Davide Martino

      Affiliations

    • Department of Neurological and Psychiatric Sciences, University of Bari, Italy
    • ,
  • Giovanni Defazio

      Affiliations

    • Department of Neurological and Psychiatric Sciences, University of Bari, Italy
    • ,
  • Gavin Giovannoni

      Affiliations

    • Queen Mary University London, Neuroimmunology Unit, Neuroscience Centre, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK
    • Corresponding Author InformationCorresponding author. Neuroscience Centre, Barts and the London School of Medicine and Dentistry, 4 Newark Street, E1 2AT London , United Kingdom. Tel.: +44 20 7377 7472; fax: +44 20 7377 7033.

Received 6 January 2009 ,Revised 8 July 2009 ,Accepted 9 July 2009.

References 

  1. Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF. Tourette syndrome and tic disorders: a decade of progress. J Am Acad Child Adolesc Psychiatry. 2007;46:947–968
  2. Swedo SE. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994;272:1788–1791
  3. Jordan LC, Singer HS. Sydenham chorea in children. Curr Treat Options Neurol. 2003;5:283–290
  4. Kiessling LS, Marcotte AC, Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics. 1993;92:39–43
  5. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264–271
  6. Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive–compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics. 2004;113:883–886
  7. Swedo SE, Leonard HL, Rapoport JL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics. 2004;113:907–911
  8. Gabbay V, Coffey BJ, Babb JS, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic. Pediatrics. 2008;122:273–278
  9. Cardona F, Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr. 2001;138:71–75
  10. Morshed SA, Parveen S, Leckman JF, et al. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry. 2001;50:566–577
  11. Muller N, Riedel M, Straube A, et al. Increased antistreptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res. 2000;94:43–49
  12. Muller N, Kroll B, Schwarz MJ, et al. Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res. 2001;101:187–193
  13. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry. 2003;74:602–607
  14. Martino D, Church AJ, Defazio G, et al. Soluble adhesion molecules in Gilles de la Tourette's syndrome. J Neurol Sci. 2005;234:79–95
  15. Rizzo R, Gulisano M, Pavone P, Fogliani F, Robertson MM. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J Child Neurol. 2006;21:747–753
  16. Loiselle CR, Wendlandt JT, Rohde CA, Singer HS. Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome. Pediatr Neurol. 2003;28:119–125
  17. Cardona F, Ventriglia F, Cipolla O, Romano A, Creti R, Orefici G. A post-streptococcal pathogenesis in children with tic disorders is suggested by a color Doppler echocardiographic study. Eur J Paediatr Neurol. 2007;11:270–276
  18. Snider LA, Sachdev V, MacKaronis JE, St. Peter M, Swedo SE. Echocardiographic findings in the PANDAS subgroup. Pediatrics. 2004;114:e748–e751
  19. Segarra AR, Murphy TK. Cardiac involvement in children with PANDAS. J Am Acad Child Adolesc Psychiatry. 2008;47:603–604
  20. Giulino L, Gammon P, Sullivan K, et al. Is parental report of upper respiratory infection at the onset of obsessive–compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?. J Child Adolesc Psychopharmacol. 2002;12:157–164
  21. Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive–compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics. 2005;116:56–60
  22. Leslie DL, Kozma L, Martin A, et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry. 2008;[Epub ahead of print]
  23. Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 2002;156:356–361
  24. Luo F, Leckman JF, Katsovich L, et al. Prospective longitudinal study of children with tic disorders and/or obsessive–compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics. 2004;113:e578–e585
  25. Perrin EM, Murphy ML, Casey JR, et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?. Arch Pediatr Adolesc Med. 2004;158:848–856
  26. March JS. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): implications for clinical practice. Arch Pediatr Adolesc Med. 2004;158:927–929
  27. Murphy TK, Sajid M, Soto O, et al. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive–compulsive disorder and tics. Biol Psychiatry. 2004;55:61–68
  28. Kurlan R, Johnson D, Kaplan EL and the Tourette Syndrome Study Group. Streptococcal infection and exacerbations of childhood tics and obsessive–compulsive symptoms: a prospective blinded cohort study. Pediatrics. 2008;121:1188–1197
  29. Murphy TK, Snider LA, Mutch PJ, et al. Relationship of movements and behaviors to group A Streptococcus infections in elementary school children. Biol Psychiatry. 2007;61:279–284
  30. Waldrep DA. Two cases of ADHD following GABHS infection: a PANDAS subgroup?. J Am Acad Child Adolesc Psychiatry. 2002;41:1273–1274
  31. Peterson BS, Leckman JF, Tucker D, et al. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive–compulsive, and attention deficit/hyperactivity disorders. Arch Gen Psychiatry. 2000;57:364–372
  32. Mercadante MT, Busatto GF, Lombroso PJ, et al. The psychiatric symptoms of rheumatic fever. Am J Psychiatry. 2000;157:2036–2038
  33. Dale RC, Heyman I, Surtees RAH, et al. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child. 2004;89:604–610
  34. Elia J, Dell ML, Friedman DF, et al. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry. 2005;44:1145–1150
  35. Kerbeshian J, Burd L, Tait A. Chain reaction or time bomb: a neuropsychiatric-developmental/neurodevelopmental formulation of tourettisms, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS. World J Biol Psychiatry. 2007;8:201–207
  36. Mathew SJ. PANDAS variant and body dysmorphic disorder. Am J Psychiatry. 2001;158:963
  37. Sokol MS. Infection-triggered anorexia nervosa in children: clinical description of four cases. J Child Adolesc Psychopharmacol. 2000;10:133–145
  38. Calkin CV, Carandang CG. Certain eating disorders may be a neuropsychiatric manifestation of PANDAS: case report. J Am Acad Child Adolesc Psychiatry. 2007;16:132–135
  39. Puxley F, Midtsund M, Iosif A, Lask B. PANDAS anorexia nervosa—endangered, extinct or nonexistent?. Int J Eat Disord. 2008;41:15–21
  40. Kuluva J, Hirsch S, Coffey B. PANDAS and paroxysms: a case of conversion disorder?. J Child Adolesc Psychopharmacol. 2008;18:109–115
  41. Hirschtritt ME, Hammond CJ, Luckenbaugh D, et al. Executive and attention functioning among children in the PANDAS subgroup. Child Neuropsychol. 2008;11:1–16
  42. Kirvan CA, Swedo SE, Kurahara D, Cunningham MW. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity. 2006;39:21–29
  43. Pavone P, Bianchini R, Parano E, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol. 2004;30:107–110
  44. Morris CM, Pardo-Villamizar C, Gause CD, Singer HS. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci. 2008;[Epub ahead of print]
  45. Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol. 2006;179:173–179
  46. Church AJ, Dale RC, Giovannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?. Arch Dis Child. 2004;89:611–614
  47. Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S, Grus FH. Anti-basal ganglia antibodies in PANDAS. Mov Disord. 2004;19:406–415
  48. Singer HS, Hong JJ, Yoon DY, Williams PN. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology. 2005;65:1701–1707
  49. Martino D, Church AJ, Dale RC, Giovannoni G. Antibasal ganglia antibodies and PANDAS. Mov Disord. 2005;20:116–117
  50. Dale RC, Church AJ, Candler PM, Chapman M, Martino D, Giovannoni G. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology. 2006;66:1612
  51. Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol. 2006;172:187–197
  52. Kansy JW, Katsovich L, McIver KS, et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol. 2006;181:165–176
  53. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914–920
  54. Archelos JJ, Hartung HP. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci. 2000;23:317–327
  55. Giedd JN, Rapoport JL, Garvey MA, Perlmutter S, Swedo SE. MRI assessment of children with obsessive–compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry. 2000;157:281–283
  56. Hallett JJ, Harling-Berg CJ, Knopf PM, Stopa EG, Kiessling LS. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol. 2000;111:195–202
  57. Taylor JR, Morshed SA, Parveen S, et al. An animal model of Tourette's syndrome. Am J Psychiatry. 2002;159:657–660
  58. Loiselle CR, Lee O, Moran TH, Singer HS. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord. 2004;19:390–396
  59. Singer HS, Mink JW, Loiselle CR, et al. Microinfusion of antineuronal antibodies into rodent striatum: failure to differentiate between elevated and low titers. J Neuroimmunol. 2005;163:8–14
  60. Liu X, Wang Y, Li D, Ju X. Transplantation of rat neural stem cells reduces stereotypic behaviors in rats after intrastriatal microinfusion of Tourette syndrome sera. Behav Brain Res. 2008;186:84–90
  61. Hoffman KL, Hornig M, Yaddanapudi K, Jabado O, Lipkin WI. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J Neurosci. 2004;24:1780–1791
  62. Leckman JF, Katsovich L, Kawikova I, et al. Increased serum levels of tumour necrosis factor-alpha and IL-12 in Tourette's syndrome. Biol Psychiatry. 2005;57:667–673
  63. Lit L, Gilbert DL, Walker W, Sharp FR. A subgroup of Tourette's patients overexpress specific natural killer cell genes in blood: a preliminary report. Am J Med Genet B. 2007;144B:958–963
  64. Kawikova I, Leckman JF, Kronig H, et al. Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry. 2007;61:273–278
  65. Singer HS, Gause C, Morris C, Lopez P Tourette Syndrome Study Group. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics. 2008;121:1198–1205
  66. Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry. 1999;45:1564–1571
  67. Snider LA, Lougee L, Slattery M, et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry. 2005;57:788–792
  68. Budman C, Coffey BJ, Dure L, et al. Regarding “antibiotic prophylaxis with azithromycin or penicillin for childhhod-onset neuropsychiatric disorders”. Biol Psychiatry. 2005;58:917
  69. Garvey MA, Swedo SE, Shapiro MB, et al. Intravenous immunoglobulin and plasmapheresis as effective treatments of Sydenham's corea. [abstract] Neurology. 1996;46:A147
  70. Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive–compulsive disorder and tic disorders in childhood. Lancet. 1999;354:1153–1158
  71. Singer HS. PANDAS and immunomodulatory therapy. Lancet. 1999;354:1137–1138
  72. Kondo K, Kabasawa T. Improvement in Gilles de la Tourette syndrome after corticosteroid therapy. Ann Neurol. 1978;4:387
  73. Geschwind N, Kondo K. Corticosteroid therapy and Tourette syndrome. Ann Neurol. 1979;5:495
  74. Matarazzo EB. Tourette's syndrome treated with ACTH and prednisone: report of two cases. J Child Adolesc Psychopharmacol. 1992;2:215–226
  75. Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1995;34:307–311
  76. Tucker DM, Leckman JF, Scahill L, et al. A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. J Am Acad Child Adolesc Psychiatry. 1996;35:1684–1691
  77. Muller N, Riedel M, Erfurth A, et al. Immunoglobulin therapy in Gilles de la Tourette syndrome. Nervenarzt. 1997;68:914–916
  78. Perlmutter SJ, Garvey MA, Castellanos X, et al. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry. 1998;155:1592–1598
  79. Hoekstra PJ, Minderaa RB, Kallenberg CGM. Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study. J Clin Psychiatry. 2004;65:537–542
  80. Nicolson R, Swedo SE, Lenane M, et al. An open trial of plasma exchange in childhood-onset obsessive–compulsive disorder without poststreptococcal exacerbations. J Am Acad Child Adolesc Psychiatry. 2000;39:1313–1315
  81. Murphy TK, Storch EA, Strawser M. SSRI-induced behavioral activation in the PANDAS subtype. Prim Psychiatry. 2006;13:87–89
  82. Storch EA, Murphy TK, Geffken GR, et al. Cognitive-behavioral therapy for PANDAS-related obsessive–compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006;45:1171–1178

PII: S0022-3999(09)00270-0

doi: 10.1016/j.jpsychores.2009.07.004

Journal of Psychosomatic Research
Volume 67, Issue 6 , Pages 547-557 , December 2009

Article Tools